These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 10531013
1. Caffeine inhibits the checkpoint kinase ATM. Blasina A, Price BD, Turenne GA, McGowan CH. Curr Biol; 1999 Oct 07; 9(19):1135-8. PubMed ID: 10531013 [Abstract] [Full Text] [Related]
2. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD, Khanna KK. J Biol Chem; 2000 Apr 07; 275(14):10342-8. PubMed ID: 10744722 [Abstract] [Full Text] [Related]
3. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. Cortez D. J Biol Chem; 2003 Sep 26; 278(39):37139-45. PubMed ID: 12847089 [Abstract] [Full Text] [Related]
7. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. Ye R, Bodero A, Zhou BB, Khanna KK, Lavin MF, Lees-Miller SP. J Biol Chem; 2001 Feb 16; 276(7):4828-33. PubMed ID: 11096068 [Abstract] [Full Text] [Related]
8. Activation of the S phase DNA damage checkpoint by mitomycin C. Mladenov E, Tsaneva I, Anachkova B. J Cell Physiol; 2007 May 16; 211(2):468-76. PubMed ID: 17167777 [Abstract] [Full Text] [Related]
9. Caffeine and human DNA metabolism: the magic and the mystery. Kaufmann WK, Heffernan TP, Beaulieu LM, Doherty S, Frank AR, Zhou Y, Bryant MF, Zhou T, Luche DD, Nikolaishvili-Feinberg N, Simpson DA, Cordeiro-Stone M. Mutat Res; 2003 Nov 27; 532(1-2):85-102. PubMed ID: 14643431 [Abstract] [Full Text] [Related]
10. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. Goodarzi AA, Lees-Miller SP. DNA Repair (Amst); 2004 Jul 02; 3(7):753-67. PubMed ID: 15177184 [Abstract] [Full Text] [Related]
11. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Siu WY, Lau A, Arooz T, Chow JP, Ho HT, Poon RY. Mol Cancer Ther; 2004 May 02; 3(5):621-32. PubMed ID: 15141020 [Abstract] [Full Text] [Related]
12. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Science; 1998 Sep 11; 281(5383):1674-7. PubMed ID: 9733514 [Abstract] [Full Text] [Related]
15. Loss of RPA1 induces Chk2 phosphorylation through a caffeine-sensitive pathway. Araya R, Hirai I, Meyerkord CL, Wang HG. FEBS Lett; 2005 Jan 03; 579(1):157-61. PubMed ID: 15620706 [Abstract] [Full Text] [Related]
16. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, Zhang X, Annan RS, Lu Q, Faucette LF, Scott GF, Li X, Carr SA, Johnson RK, Winkler JD, Zhou BB. Oncogene; 1999 Jul 15; 18(28):4047-54. PubMed ID: 10435585 [Abstract] [Full Text] [Related]
17. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive. Guo N, Faller DV, Vaziri C. Cell Growth Differ; 2002 Feb 15; 13(2):77-86. PubMed ID: 11864911 [Abstract] [Full Text] [Related]
18. Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase. Alby F, Mazars R, de Rycke J, Guillou E, Baldin V, Darbon JM, Ducommun B. FEBS Lett; 2001 Mar 02; 491(3):261-5. PubMed ID: 11240139 [Abstract] [Full Text] [Related]
19. The mismatch repair system is required for S-phase checkpoint activation. Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R. Nat Genet; 2003 Jan 02; 33(1):80-4. PubMed ID: 12447371 [Abstract] [Full Text] [Related]
20. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G, Besnard E, Fisher D, Piette J, Dulić V. Oncogene; 2011 Oct 13; 30(41):4261-74. PubMed ID: 21532626 [Abstract] [Full Text] [Related] Page: [Next] [New Search]